Ocrelizumab Alters Cytotoxic Lymphocyte Function While Reducing EBV-Specific CD8+ T-Cell Proliferation in Patients With Multiple Sclerosis
Article in Neurology Neuroimmunology & Neuroinflammation (April 2024)
The most recent citing publications are shown below. View all 44 publications that cite this research output on Dimensions.
Article in Neurology Neuroimmunology & Neuroinflammation (April 2024)
Article in Multiple Sclerosis Journal (April 2024)
Article in Cell Communication and Signaling (February 2024)